(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.11%) $0.928
(0.28%) $10.87
(-0.03%) $0.792
(-0.03%) $92.55
Live Chart Being Loaded With Signals
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors...
Stats | |
---|---|
Today's Volume | 230 000 |
Average Volume | 401 628 |
Market Cap | 735.93M |
EPS | HKD0 ( 2024-03-20 ) |
Next earnings date | ( HKD0 ) 2024-04-24 |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -0.900 |
ATR14 | HKD0.0140 (0.79%) |
JW THERAP-B Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
JW THERAP-B Financials
Annual | 2022 |
Revenue: | HKD145.70M |
Gross Profit: | HKD58.76M (40.33 %) |
EPS: | HKD-2.06 |
Q2 | 2023 |
Revenue: | HKD87.74M |
Gross Profit: | HKD44.81M (51.07 %) |
EPS: | HKD-0.930 |
Q4 | 2022 |
Revenue: | HKD79.70M |
Gross Profit: | HKD35.63M (44.70 %) |
EPS: | HKD-1.010 |
Q2 | 2022 |
Revenue: | HKD66.01M |
Gross Profit: | HKD23.13M (35.04 %) |
EPS: | HKD-1.050 |
Financial Reports:
No articles found.
JW THERAP-B
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators